Evidence map›Paper›PMID 29128673›Full record

ArticleThe Journal of allergy and clinical immunology2018

Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation.

Venetia Bigley, Sheetal Maisuria, Urszula Cytlak, Laura Jardine, Matthew A Care, Kile Green, Merry Gunawan, Paul Milne, Rachel Dickinson, Sarah Wiscombe and 13 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The Journal of allergy and clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Pooled it
  2. Macrophage heterogeneity in human secondary lymphoid organs.Clinical science (London, England : 1979) · 2026
    Review
  3. Review
  4. Human immunity to fungal infections.The Journal of experimental medicine · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Circulating IRF8-expressing CD123Trends in immunology · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Dendritic cells in inborn errors of immunity.Frontiers in immunology · 2023
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 1 country.

Venetia BigleyInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom. Electronic address: Venetia.bigley@ncl.ac.uk.
Sheetal MaisuriaLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
Urszula CytlakInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Laura JardineInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Matthew A CareLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
Kile GreenInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Merry GunawanInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Paul MilneInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Rachel DickinsonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Sarah WiscombeInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
David ParryLeeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom.
Rainer DoffingerDepartment of Clinical Biochemistry and Immunology, Addenbrookes Hospital, Cambridge, United Kingdom.
Arian LaurenceInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Claudia FonsecaCambridge Protein Arrays, Babraham Research Campus, Cambridge, United Kingdom.
Oda StoevesandtCambridge Protein Arrays, Babraham Research Campus, Cambridge, United Kingdom.
Andrew GenneryInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Andrew CantNewcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Reuben ToozeLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
A John SimpsonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Sophie HambletonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Sinisa SavicNational Institute for Health Research-Leeds Musculoskeletal Biomedical Research Unit and Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
Gina DoodyLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
Matthew CollinInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Newcastle upon Tyne Hospitals NHS Foundation Trust · GBNewcastle University · GBUniversity of Leeds · GBBabraham Institute · GBAddenbrooke's Hospital · GB

Funding

Cancer Research UK 21025Cancer Research UK C30484/A21025Cancer Research UK C7845/A17723Department of HealthWellcome Trust 101155Wellcome Trust 101155/Z13/Z
6 · The paper itself

Abstract

backgroundThe homozygous K108E mutation of interferon regulatory factor 8 (IRF8) is reported to cause dendritic cell (DC) and monocyte deficiency. However, more widespread immune dysfunction is predicted from the multiple roles ascribed to IRF8 in immune cell development and function.

objectiveWe sought to describe the effect on hematopoiesis and immunity of the compound heterozygous R83C/R291Q mutation of IRF8, which is present in a patient with recurrent viral infection, granuloproliferation, and intracerebral calcification.

methodsVariant IRF8 alleles were identified by means of exome sequencing, and their function was tested by using reporter assays. The cellular phenotype was studied in detail by using flow cytometry, functional immunologic assay transcriptional profiling, and antigen receptor profiling.

resultsBoth mutations affected conserved residues, and R291Q is orthologous to R294, which is mutated in the BXH2 IRF8-deficient mouse. R83C showed reduced nuclear translocation, and neither mutant was able to regulate the Ets/IRF composite element or interferon-stimulated response element, whereas R291Q retained BATF/JUN interactions. DC deficiency and monocytopenia were observed in blood, dermis, and lung lavage fluid. Granulocytes were consistently increased, dysplastic, and hypofunctional. Natural killer cell development and maturation were arrested. T

conclusionsThis analysis defines the clinical features of human biallelic IRF8 deficiency, revealing a complex immunodeficiency syndrome caused by DC and monocyte deficiency combined with widespread immune dysregulation.

Indexed as

Dendritic CellsHumansImmunologic Deficiency SyndromesInterferon Regulatory Factor-8Interferon Regulatory FactorsMaleMonocytesMutationInterferon Regulatory Factor-8Interferon Regulatory Factorsdendritic cellimmunodeficiencyinterferonInterferon regulatory factor 8monocytemyeloproliferation

Identifiers

PMID29128673
PMCPMC5986711
OpenAlexW2767814127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.